BOSTON - Douglas Hanto, MD, PhD, chief of the Transplant Institute at Beth Israel Deaconess Medical Center, has been elected as a director of the American Board of Surgery (ABS).
Hanto, the Lewis Thomas Professor of Surgery at Harvard Medical School, will represent the American Society of Transplant Surgeons (ASTS). His six-year-term on the 38-member will begin on July 1.
As a director, Hanto will take part in setting the standards for board certification and maintenance of certification in general surgery and its related subspecialties in the United States. He will also participate in the development of ABS examinations and as an examiner in the oral examinations that are given as part of the board certification process.
In particular, he will contribute his expertise in the field of transplant surgery.
ABS directors are distinguished surgeons in education, research and practice, and represent the principal surgical organizations in the U.S. The ABS is one of the 24 member boards of the American Board of Medical Specialties.
The American Board of Surgery (ABS) is an independent, non-profit organization founded in 1937 for the purpose of certifying surgeons who have met a defined standard of education, training and knowledge. Surgeons certified by the ABS, known as diplomates, have completed a minimum of five years of surgical residency training following medical school and successfully completed a written and oral examination process administered by the ABS.
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School, and consistently ranks among the top four in National Institutes of Health funding among independent hospitals nationwide. BIDMC is clinically affiliated with the Joslin Diabetes Center and is a research partner of Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit